We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Get past the taste

1 March 2005 By Robert Cyran

The merger that created the French pharma giant may have made the markets sick, but it looks surprisingly successful so far. Proposed synergies from combining the two companies always involved vague promises, but the group is ahead of schedule.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)